In Review, Top F.D.A. Scientists Question Imminent Need for Booster Shots

An article, written with other vaccine experts, put the regulators at odds with key federal health officials, including Dr. Anthony S. Fauci.

F.D.A. Seeks Investigation of Its Own Alzheimer’s Drug Approval

The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.

F.D.A. Still Lacks a Permanent Chief, Despite Pressing, Weighty Problems

With the pandemic easing, the federal agency’s long-term agenda for drug approvals or new issues is languishing without a permanent commissioner.